GOLDEN, Colo. — May 7, 2019 — PharmaJet®, the maker of innovative, needle-free injection technology, today shared that their latest research results were presented at the World Vaccine Congress on April 16, in Washington DC at the Renaissance Washington DC Downtown Hotel. The presentation, entitled Expanding Vaccine Effective-ness with Needle-free Delivery, was presented by Dr. Marilyn Dysart, Clinical Affairs Manager at PharmaJet, Inc.
GOLDEN, Colo. — November 27, 2018 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced plans to present their latest re-search results at the World Vaccine & Immunotherapy Congress on November 29 at the Loews Coronado Bay Resort in San Diego, California. The presentation, entitled Expanding Vaccine Effectiveness with Needle-free Delivery, will be presented by Dr. Erin Spiegel, Director of Scientific Affairs at PharmaJet, Inc.
Immunization coverage is critical to eradicating potentially deadly diseases while reducing the burden of disease. Safe, cost-effective, and patient-friendly injectable drug delivery systems play a crucial role in the success of global vaccination programs. PharmaJet leverages innovative jet injection technology to offer a needle-free, accurate, and more comfortable method of vaccine delivery. With unparalleled ease-of-use…
GeoVax Labs, Inc. announced that it is collaborating with PharmaJet on the evaluation of the needle-free injection system for administration of their Zika vaccine.
SINGAPORE — July 25, 2018 — PharmaJet® the maker of innovative, needle-free injection technology, and Mundipharma, today announced an exclusive partnership for the multinational healthcare organization to market and distribute PharmaJet’s Tropis® and Stratis® needle-free devices across more than 120 markets worldwide. Tropis® (ID) and Stratis® (IM/SC) devices are both optimized for vaccine immunizations.
InnoSTARS crowned a hot, new medical technology winner delivering an exciting shot to the arm of the technology landscape with its breakthrough innovation gaining international attention.